cobaltous chloride has been researched along with Carcinoma, Anaplastic in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brimmell, M; Lapham, A; Lee, M; Packham, G; Wilkinson, H | 1 |
Brabant, G; Burrows, N; Cowen, RL; Hoang-Vu, C; Resch, J; von Wasielewski, R; West, CM; Williams, KJ | 1 |
Koga, F; Neckers, LM; Tsutsumi, S | 1 |
Ardyanto, TD; Ito, H; Maeta, N; Nagahama, Y; Osaki, M; Tamura, T; Yamaga, K | 1 |
Chandel, NS; Schumacker, PT; Thompson, CB; Vander Heiden, MG | 1 |
5 other study(ies) available for cobaltous chloride and Carcinoma, Anaplastic
Article | Year |
---|---|
Inhibition of proteasomal degradation of Mcl-1 by cobalt chloride suppresses cobalt chloride-induced apoptosis in HCT116 colorectal cancer cells.
Topics: Antimutagenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Binding Sites; Carcinoma; Cell Line, Tumor; Cell Survival; Cobalt; Colorectal Neoplasms; Dose-Response Relationship, Drug; Down-Regulation; Feedback, Physiological; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Myeloid Cell Leukemia Sequence 1 Protein; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Ubiquitination | 2008 |
Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas.
Topics: Adenocarcinoma, Follicular; Anaerobiosis; Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma; Carcinoma, Papillary; Cell Hypoxia; Cell Line, Tumor; Chromones; Cobalt; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Morpholines; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins B-raf; PTEN Phosphohydrolase; RNA Interference; RNA, Small Interfering; Signal Transduction; Thyroid Neoplasms | 2010 |
Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells.
Topics: Antibiotics, Antineoplastic; Benzoquinones; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Cobalt; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; Extracellular Matrix Proteins; Feedback, Physiological; Female; Fibronectins; Focal Adhesions; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; HSP90 Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Integrin beta3; Lactams, Macrocyclic; Neoplasm Invasiveness; Neoplasm Proteins; Neovascularization, Pathologic; Proto-Oncogene Proteins c-met; Stress Fibers; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A | 2007 |
Down-regulation of cobalt-induced HIF-1alpha expression correlates with cell proliferation and apoptosis in human gastric carcinoma cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Carcinoma; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cobalt; Down-Regulation; Flow Cytometry; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Stomach Neoplasms | 2008 |
Redox regulation of p53 during hypoxia.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Acetylcysteine; Animals; Antioxidants; Breast Neoplasms; Carcinoma; Cell Cycle; Cell Death; Cell Division; Cell Hypoxia; Cells, Cultured; Chick Embryo; Cobalt; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Ditiocarb; Fibroblasts; Fluoresceins; Humans; Hydrogen Peroxide; Mice; Mitochondria; Myocardium; Reactive Oxygen Species; Rotenone; Superoxide Dismutase; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uncoupling Agents | 2000 |